日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

miR-30a-3p inhibits the proliferation of liver cancer cells by targeting DNMT3a through the PI3K/AKT signaling pathway

miR-30a-3p通过PI3K/AKT信号通路靶向DNMT3a抑制肝癌细胞增殖

Qiong Chen, Yuan Gao, Qin Yu, Feng Tang, Pei-Wei Zhao, Su-Kun Luo, Ju-Sheng Lin, Hong Mei

The ASH1-miR-375-YWHAZ Signaling Axis Regulates Tumor Properties in Hepatocellular Carcinoma

ASH1-miR-375-YWHAZ 信号轴调节肝细胞癌的肿瘤特性

Juan-Feng Zhao, Qiu Zhao, Hui Hu, Jia-Zhi Liao, Ju-Sheng Lin, Chao Xia, Ying Chang, Jing Liu, An-Yuan Guo, Xing-Xing He

miR-195 inhibits cell proliferation via targeting AEG-1 in hepatocellular carcinoma

miR-195 通过靶向 AEG-1 抑制肝细胞癌中的细胞增殖

Jing-Jun Yan, Ying Chang, Yu-Nan Zhang, Ju-Sheng Lin, Xing-Xing He, Huan-Jun Huang

Serum metabolomics profiles in response to n-3 fatty acids in Chinese patients with type 2 diabetes: a double-blind randomised controlled trial

中国2型糖尿病患者血清代谢组学对n-3脂肪酸反应的研究:一项双盲随机对照试验

Zheng, Ju-Sheng; Lin, Mei; Imamura, Fumiaki; Cai, Wenwen; Wang, Ling; Feng, Jue-Ping; Ruan, Yue; Tang, Jun; Wang, Fenglei; Yang, Hong; Li, Duo

MiR-497 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting VEGFA and AEG-1

MiR-497 通过抑制 VEGFA 和 AEG-1 抑制肝细胞癌的血管生成和转移

Jing-Jun Yan, Yu-Nan Zhang, Jia-Zhi Liao, Kun-peng Ke, Ying Chang, Pei-Yuan Li, Min Wang, Ju-Sheng Lin, Xing-Xing He

MiR-192 inhibits nucleotide excision repair by targeting ERCC3 and ERCC4 in HepG2.2.15 cells

MiR-192 通过靶向 ERCC3 和 ERCC4 抑制 HepG2.2.15 细胞中的核苷酸切除修复

Qiong-Hui Xie, Xing-Xing He, Ying Chang, Shu-zhen Sun, Xiang Jiang, Pei-Yuan Li, Ju-Sheng Lin